Braveheart Bio
Develops therapies for hypertrophic cardiomyopathy and cardiovascular disease.
BiotechnologyPharmaceuticals
Company facts
- Founded
- 2025
- Employees
- 40
- Headquarters
- United States
- Type
- Private
- Funding
- Series A · $185M · 2025
Develops therapies for hypertrophic cardiomyopathy and cardiovascular disease.
Company facts